Related Experiment Videos
Immunoregulatory effect of substance P in human eosinophil migratory function
A E El-Shazly1, K Masuyama, M Eura
1Department of Otorhinolaryngology, School of Medicine, Kumamoto University, Japan.
Immunological Investigations
|May 1, 1996
Summary
Substance P (SP) primes human eosinophils, enhancing their migration in response to inflammatory signals like PAF and IL-5. This neurogenic effect suggests a role for nerve-derived signals in allergic inflammation.
Area of Science:
- Immunology
- Neuroscience
- Cell Biology
Background:
- Substance P (SP) is a neuropeptide regulating inflammatory processes.
- Eosinophils are key cells in allergic inflammation.
- The role of SP in modulating eosinophil function during allergic responses requires further investigation.
Purpose of the Study:
- To investigate the modulatory role of neuropeptide SP in allergic inflammation.
- To determine the priming effect of SP on human eosinophil chemotaxis and kinetic responses.
- To examine the synergistic effects of SP with platelet-activating factor (PAF) and recombinant human interleukin-5 (rhIL-5).
Main Methods:
- Human eosinophils were isolated using Percoll density gradient centrifugation and CD16-bead negative selection.
- Microchemotaxis assays were performed in a 48-well Boyden chamber.
- The effects of SP, PAF, rhIL-5, and an NK-1 receptor antagonist (FK888) on eosinophil migration were evaluated.
Main Results:
- Substance P (100nM) demonstrated a potent synergistic effect on human eosinophil migration stimulated by PAF and rhIL-5.
- This synergistic effect was specific to chemotaxis.
- The observed synergism was blocked by the NK-1 receptor antagonist FK888.
Conclusions:
- Neuropeptide SP primes human eosinophils, significantly enhancing their migratory response to inflammatory mediators.
- Neurogenic stimuli, through SP, may play a crucial role in eosinophil recruitment during allergic inflammation.
- Targeting the NK-1 receptor could be a potential therapeutic strategy for allergic inflammatory diseases.